Beta blocker treatment in heart failure

被引：33

作者：

Carson, PE ^{[1
]}

机构：

[1] Vet Affairs Med Ctr, Dept Vet Affairs, Washington, DC 20422 USA

来源：

PROGRESS IN CARDIOVASCULAR DISEASES | 1999年 / 41卷 / 04期

关键词：

D O I：

10.1053/pcad.1999.0410301

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

The sympathetic nervous system occupies a prominent role in heart failure both as a marker of severity of disease and also as an important factor in its progression. Beta blocker therapy, once thought heretical in heart failure, has consistently improved cardiac function and slowed progression of disease. Large clinical trials of mild to moderate heart failure show improved survival as well as reduction in hospitalization. Beta blockers now have stronger data in heart failure than converting enzyme inhibitors, and should be considered standard therapy in mild-moderate heart failure. Ongoing trials are addressing beta blocker therapy in advanced heart failure and comparisons between agents.

引用

页码：301 / 321

页数：21

共 67 条

[1]

*AM HEART ASS, 1997 HEART STROK STA

[2]

ANDERSON JL, 1995, AM J CARDIOL, V75, P1220

[3]

ANDERSON JL, 1985, AM J CARDIOL, V55, P417

[4] PARASYMPATHETIC WITHDRAWAL IS AN INTEGRAL COMPONENT OF AUTONOMIC IMBALANCE IN CONGESTIVE-HEART-FAILURE - DEMONSTRATION IN HUMAN-SUBJECTS AND VERIFICATION IN A PACED CANINE MODEL OF VENTRICULAR FAILURE [J].

BINKLEY, PF ;

NUNZIATA, E ;

HAAS, GJ ;

NELSON, SD ;

CODY, RJ .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1991, 18 (02) :464-472

[5] CARDIOPROTECTIVE EFFECTS OF CARVEDILOL, A NOVEL BETA-ADRENOCEPTOR ANTAGONIST WITH VASODILATING PROPERTIES, IN ANESTHETIZED MINIPIGS - COMPARISON WITH PROPRANOLOL [J].

BRIL, A ;

SLIVJAK, M ;

DIMARTINO, MJ ;

FEUERSTEIN, GZ ;

LINEE, P ;

POYSER, RH ;

RUFFOLO, RR ;

SMITH, EF .

CARDIOVASCULAR RESEARCH, 1992, 26 (05) :518-525

[6] Carvedilol produces dose-related improvements in left ventricular function and survival in subjects with chronic heart failure [J].

Bristow, MR ;

Gilbert, EM ;

Abraham, WT ;

Adams, KF ;

Fowler, MB ;

Hershberger, RE ;

Kubo, SH ;

Narahara, KA ;

Ingersoll, H ;

Krueger, S ;

Young, S ;

Shusterman, N .

CIRCULATION, 1996, 94 (11) :2807-2816

[7] DOSE-RESPONSE OF CHRONIC BETA-BLOCKER TREATMENT IN HEART-FAILURE FROM EITHER IDIOPATHIC DILATED OR ISCHEMIC CARDIOMYOPATHY [J].

BRISTOW, MR ;

OCONNELL, JB ;

GILBERT, EM ;

FRENCH, WJ ;

LEATHERMAN, G ;

KANTROWITZ, NE ;

ORIE, J ;

SMUCKER, ML ;

MARSHALL, G ;

KELLY, P ;

DEITCHMAN, D ;

ANDERSON, JL .

CIRCULATION, 1994, 89 (04) :1632-1642

[8] BETA-ADRENERGIC FUNCTION IN HEART-MUSCLE DISEASE AND HEART-FAILURE [J].

BRISTOW, MR ;

KANTROWITZ, NE ;

GINSBURG, R ;

FOWLER, MB .

JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 1985, 17 :41-52

[9] BETA-1-ADRENERGIC-RECEPTOR AND BETA-2-ADRENERGIC-RECEPTOR SUBPOPULATIONS IN NONFAILING AND FAILING HUMAN VENTRICULAR MYOCARDIUM - COUPLING OF BOTH RECEPTOR SUBTYPES TO MUSCLE-CONTRACTION AND SELECTIVE BETA-1-RECEPTOR DOWN-REGULATION IN HEART-FAILURE- [J].

BRISTOW, MR ;

GINSBURG, R ;

UMANS, V ;

FOWLER, M ;

MINOBE, W ;

RASMUSSEN, R ;

ZERA, P ;

MENLOVE, R ;

SHAH, P ;

JAMIESON, S ;

STINSON, EB .

CIRCULATION RESEARCH, 1986, 59 (03) :297-309

[10] DECREASED CATECHOLAMINE SENSITIVITY AND BETA-ADRENERGIC-RECEPTOR DENSITY IN FAILING HUMAN HEARTS [J].

BRISTOW, MR ;

GINSBURG, R ;

MINOBE, W ;

CUBICCIOTTI, RS ;

SAGEMAN, WS ;

LURIE, K ;

BILLINGHAM, ME ;

HARRISON, DC ;

STINSON, EB .

NEW ENGLAND JOURNAL OF MEDICINE, 1982, 307 (04) :205-211

← 1 2 3 4 5 6 7 →